Stress hormone responses to corticotropin-releasing hormone in substance abusers without severe comorbid psychiatric disease

Biological Psychiatry

Volumn 54, Issue 9, 2003, Pages 873-878

  Contoreggi, Carlo ^a,e   Herning, Ronald I ^a   Na, Paul ^a   Gold, Philip W ^c   Chrousos, George ^d   Negro, Paulo J ^b   Better, Warren ^a   Cadet, Jean L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e Brain Imaging Section   (United States)

Author keywords

Adrenocorticotrophin; Corticotropin releasing hormone; Cortisol; Substance abuse

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HORMONE; HYDROCORTISONE;

ADRENAL GLAND; ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; FEMALE; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; STIMULATION; SUBSTANCE ABUSE; SYMPTOM;

EID: 0142250803     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00167-7     Document Type: Article

References (30)

1. Beck A.T., Weissman A., Lester D., Trexler L. The measurement of pessimism The hopelessness scale . J Consult Clin Psychol. 42:1974;861-865.
2. Cador M., Cole B.J., Koob G.F., Stinus L., Le Moal M. Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine. Brain Res. 606:1993;181-186.
3. Coiro V., Vescovi P.P. Effect of cigarette smoking on ACTH/cortisol secretion in alcoholic after short- and medium-term abstinence. Alcohol Clin Exp Res. 23:1999;1515-1518.
4. Derogatis L.R. Administration, Scoring, and Procedures for SCL-90R Manual II . 1983;Clinical Psychometric Research, Towson, MD.
5. De Souza E.B. Corticotropin-releasing factor receptors in the rat central nervous system Characterization and regional distribution . J Neurosci. 7:1987;88-100.
6. De Souza E.B., Perrin M.H., Insel T.R., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors in rat forebrain Autoradiographic identification . Science. 224:1984;1449-1451.
7. Ellison C.W. Spiritual well-being Conceptualization, and measurement . J Psychol Theol. 11:1983;330-340.
8. Errico A.L., Parsons O.A., King A.C., Lovallo W.R. Attenuated cortisol response to biobehavioral stressors in sober alcoholics. J Stud Alcohol. 54:1993;393-398.
9. Gold P., Loriaux D., Roy A., Kling M., Calabrese J., Kellner C., et al. Responses to corticotrophin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med. 314:1986;1329-1335.
10. Grigoriadis D.E., Heroux J.A., De Souza E.B. Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems. Ciba Found Symp. 172:1993;85-101.
11. Grigoriadis D.E., Zaczek R., Pearsall D.M., De Souza E.B. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain Characterization of an active digitonin-solubilized receptor complex . Endocrinology. 125:1989;3068-3077.
12. Habib K.E., Weld K.P., Rice K.C., Pushkas J., Champoux M., Listwak S., et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A. 97:2000;6079-6084.
13. Helzer J.E., Robins L.N. The diagnostic interview schedule Its development, evolution, and use . Soc Psychiatry Psychiatr Epidemiol. 23:1988;6-16.
14. Kemper A., Koalick F., Thiele H., Retzow A., Rathsack R., Nickel B. Cortisol and beta-endorphin response in alcoholics and alcohol abusers following a high naloxone dosage. Drug Alcohol Depend. 25:1990;319-326.
15. Lovallo W.R., Dickensheets S.L., Myers D.A., Thomas T.L., Nixon S.J. Blunted stress cortisol response in abstinent alcoholic and polysubstance- abusing men. Alcohol Clin Exp Res. 24:2000;651-658.
16. McLellan A.T., Luborsky L., Cacciola J., Griffith J., McGaham P., O'Brien C.P. Guide to the Addiction Severity Index Background, Administration, and Field Testing Results . 1986;National Institute on Drug Abuse, Treatment Research Reports, Rockville, MD.
17. Meier C.A., Biller B.M. Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am. 26:1997;741-762.
18. Newell-Price J., Trainer P., Besser M., Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev. 19:1998;647-672.
19. O'Toole S.M., Sekula L.K., Rubin R.T. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression. Biol Psychiatry. 42:1997;85-89.
20. Robins S., Helzer J.E., Cuttler L., Golding E. National Institute of Mental Health Diagnostic Interview Schedule Version III-R. 1988;U.S. Government Printing Office, Washington, DC.
21. Rodriguez de Fonseca F., Carrera M.R.A., Navarro M., Koob G.F., Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science. 276:1997;2050-2054.
22. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 675:1995;89-97.
23. Sarnyai Z., Hohn J., Szabo G., Penke B. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci. 51:1992;2019-2024.
24. Shaham Y., Erb S., Leung S., Buczek Y., Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl). 137:1998;184-190.
25. Shaham Y., Erb S., Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats A review . Brain Res Brain Res Rev. 33:2000;13-33.
26. Stine S.M., Grillon C.G., Morgan C.A. 3rd, Kosten T.R., Charney D.S., Krystal J.H. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology (Berl). 154:2001;274-281.
27. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
28. Vescovi P.P., DiGennaro C., Coiro V. Hormonal (ACTH, cortisol, beta-endorphin, and met-enkephalin) and cardiovascular responses to hyperthermic stress in chronic alcoholics. Alcohol Clin Exp Res. 21:1997;1195-1198.
29. Wong M.L., Webster E.L., Spokes H., Phu P., Ehrhart-Bornstein M., Bornstein S., et al. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci. 65:1999;PL53-PL58.
30. Zobel A.W., Nickel T., Kunzel H.E., Ackl N., Sonntag A., Ising M., Holsboer F. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression The first 20 patients treated . J Psychiatr Res. 34:2000;171-181.